Home
News
Create
Screeners
Insights
Achyut Healthcare
6.
73
+0.47
(+7.51%)
Market Cap
₹162.44 Cr
PE Ratio
626.00
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+7.51%
1M
+27.95%
6M
+19.12%
1Y
+92.29%
5Y
+566.34%
View Company Insights
Latest news about Achyut Healthcare
Achyut Healthcare FY26 revenue surges, net profit at ₹31.57 lakh
8 days ago
Achyut Healthcare reported a 280% increase in revenue to ₹1,159.47 lakh for FY26, though net profit declined to ₹31.57 lakh from ₹51.47 lakh in the previous year. The board approved the audited results, appointed an internal auditor, and noted the adoption of Indian Accounting Standards (Ind AS) following its migration to the BSE Main Board.
Achyut Healthcare Limited Receives BSE Listing Approval for 58,00,000 Equity Shares on Preferential Basis
May 08, 2026
Achyut Healthcare Promoter Increases Stake to 8.95% Through Preferential Allotment
Mar 25, 2026
Zenith Life Care Acquires 2,00,000 Shares in Achyut Healthcare Through Preferential Allotment
Mar 24, 2026
Ray Remedies Files SEBI Disclosure After Acquiring Additional Achyut Healthcare Shares
Mar 24, 2026
More news about Achyut Healthcare
13
Mar 26
AKSHIT M. RAYCHA HUF Files SEBI Disclosure for Share Acquisition in Achyut Healthcare
AKSHIT M. RAYCHA HUF has formally disclosed the acquisition of 10,985 additional equity shares in Achyut Healthcare Limited under SEBI regulations. The open market purchase increased the promoter group entity's shareholding from 1.92% to 1.93%, with the transaction completed on March 12, 2026. The regulatory filing was submitted to BSE's Listing Compliance Department with complete documentation as required under substantial acquisition regulations.
12
Mar 26
Achyut Healthcare Limited Receives BSE In-Principle Approval for Preferential Issue of 58,00,000 Equity Shares
Achyut Healthcare Limited has obtained BSE in-principle approval for preferential allotment of 58,00,000 equity shares of Re.1/- each at minimum ₹5 per share to promoters and non-promoters. The approval, granted under SEBI LODR Regulations, requires strict compliance with multiple regulatory frameworks and mandates specific internal controls. The company must apply for listing within twenty days of allotment and fulfill comprehensive post-issue formalities.
21
Jan 26
Achyut Healthcare Reports Q3FY26 Results, Announces ₹3.48 Crore Preferential Issue and Capital Expansion Plans
Achyut Healthcare Limited reported Q3FY26 results with total income of ₹161.12 lakhs and net profit of ₹0.43 lakhs for the quarter ended December 31, 2025. The Board approved a preferential issue of 58 lakh equity shares worth ₹3.48 crores at ₹6 per share, increased authorized capital from ₹24 crores to ₹26 crores, and relocated the registered office within Ahmedabad. An EGM is scheduled for February 19, 2026, to seek shareholder approval for these initiatives.
02
Jan 26
Achyut Healthcare Gets BSE Approval to Migrate from SME to Main Board Platform
Achyut Healthcare Limited has successfully obtained BSE approval to migrate its equity shares from the SME platform to the Main Board Platform, with trading set to begin on January 02, 2026. The Small Cap pharmaceutical company, with a market cap of ₹133.80 crores, has completed all regulatory requirements for this significant corporate milestone that enhances investor accessibility.
26
Dec 25
Akshit Raychahuf Increases Achyut Healthcare Stake to 1.52% via Open Market
Promoter Akshit M. Raychahuf has systematically increased his shareholding in Achyut Healthcare Limited through multiple open market transactions conducted between November and December. Starting with acquisitions of 31,500 shares each on November 17 and 18, he raised his stake from 1.49% to 1.52%, followed by additional purchases in December that brought his total ownership to 1.92%.
07
Nov 25
Akshit M. Raychahuf Boosts Stake in Achyut Healthcare Limited
Akshit M. Raychahuf, a promoter of Achyut Healthcare Limited, has increased his stake in the company through open market transactions. He acquired 94,500 shares, raising his shareholding from 31,21,020 shares (1.32%) to 32,15,520 shares (1.37%). The transaction was disclosed in compliance with SEBI regulations.
06
Nov 25
Promoter Akshit M. Raychahuf Boosts Stake in Achyut Healthcare Limited
Akshit M. Raychahuf, a promoter of Achyut Healthcare Limited, has acquired 94,500 shares (0.04% of total share capital) through open market transactions on November 4, 2025. This increased his shareholding from 30,26,520 (1.28%) to 31,21,020 (1.32%) shares. The company's total equity share capital stands at Rs. 23,55,57,000, comprising 23,55,57,000 shares with a face value of Re. 1 each.
Achyut Healthcare
6.
73
+
0.
47
(+
7.
51
%)
1 Year Returns:
+92.29%
Industry Peers
Sun Pharmaceutical
1,783.80
(+
0.
21
%)
Divis Laboratories
6,619.50
(+
0.
35
%)
Torrent Pharmaceuticals
4,422.00
(+
1.
89
%)
Cipla
1,400.60
(+
0.
14
%)
Zydus Life Science
1,089.00
(+
0.
41
%)
Dr Reddys Laboratories
1,278.70
(+
0.
88
%)
Lupin
2,265.70
(+
0.
71
%)
Mankind Pharma
2,335.80
(-
0.
73
%)
Aurobindo Pharma
1,459.40
(-
0.
29
%)
Laurus Labs
1,445.30
(+
1.
27
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar